Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Standard Biotools Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 72 | 1 | 86 | +15 |
| Shares | 47.4M | 20.4K | 48.6M | +1.18M (+2.5%) |
| Value | $137.5M | $59.1K | $107.4M | −$30.1M (−21.9%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Standard Biotools Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (9)
Institutions that held Standard Biotools Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| EAM Investors, LLC | 473,982 | $1.37M |
| D. E. Shaw & Co., Inc. | 144,598 | $419.3K |
| Dimensional Fund Advisors LP | 54,398 | $157.8K |
| Point72 Asset Management, L.P. | 34,582 | $100.3K |
| Algert Global LLC | 26,090 | $75.7K |
| Qube Research & Technologies Ltd | 19,085 | $55.3K |
| Group One Trading, L.P. | 9,506 | $27.6K |
| Park Place Capital Corp | 2,808 | $8.14K |
| Federated Hermes, Inc. | 498 | $1.44K |
Not filed for Q4 2023 yet (1)
Institutions that held Standard Biotools Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Freedom Wealth Alliance, LLC | 20,394 | $59.1K |